Even if this gets a patent, and even if they get FDA approved, which are HUGE ifs on their own rights, there is no real market for this drug, they already have other treatments out there which are almost as effective, and 10x cheaper than this. This isn't a cure for cancer here that some want it to be. And the company has no money, hence why he is diluting the stock as soon as it had any positive move, something I expect to continue just to fund the company.